Lymphoma patient recovered in Al-Kharj | King Khalid Hospital

Lymphoma patient recovered in Al-Kharj | King Khalid Hospital

November 27, 2025
7 mins read
A medical team at King Khalid Hospital in Al-Kharj successfully treated a resident in his fifties with advanced lymphoma (DLBCL) using the R-CHOP protocol, reflecting the development of healthcare in the Kingdom.

In a remarkable medical achievement reflecting the great development in the healthcare sector in the Kingdom of Saudi Arabia, a specialized medical team at King Khalid Hospital in Al-Kharj Governorate, affiliated with the First Riyadh Health Cluster, succeeded in saving the life of a resident in his fifties after a battle with an advanced stage of lymphoma.

Case details and accurate diagnosis

The patient arrived at the hospital's emergency department suffering from severe and alarming symptoms, including severe anemia, a persistent high fever, significant loss of appetite and weight, and general weakness that affected his mobility. The medical team, led by hematologist Dr. Ali Al-Wahibi, immediately began a series of advanced laboratory and imaging tests. The results, including a complete blood count and a lymph node biopsy, confirmed a diagnosis of diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin lymphoma, with the case being advanced to stage IV and showing widespread cancer cell dissemination.

What is DLBCL lymphoma?

Degenerative lymphoma (DLBCL) is a rapidly growing malignant tumor that originates in B-cells, a key component of the immune system. Historically, a diagnosis of this disease in its advanced stages carried a grim prognosis, but medical advancements in recent decades, particularly in chemotherapy and immunotherapy, have dramatically changed this reality, offering real opportunities for complete recovery, even in metastatic cases.

A global treatment plan and promising results

Based on the diagnosis, the medical team developed an intensive treatment plan based on the R-CHOP protocol, a globally recognized treatment standard that has proven highly effective in treating this type of cancer. The plan included six doses of targeted chemotherapy and immunotherapy. The patient responded positively to the treatment, and after completing the prescribed doses, CT scans showed significant tumor shrinkage and remarkable clinical improvement. To confirm complete eradication of the disease, a bone marrow biopsy was performed, which confirmed the complete absence of any cancerous cells, leading the patient to enter full remission.

The importance of achievement and its role in realizing Vision 2030

This success is not only a story of hope for a patient and their family, but also tangible proof of the quality of specialized healthcare now available in hospitals in outlying cities like Al-Kharj, not just in major medical centers. This achievement reflects the successful integration within the Riyadh Health Cluster I, which aims to efficiently distribute advanced medical services. This progress also aligns with the objectives of the Health Sector Transformation Program and the Kingdom's Vision 2030, which seeks to build a vibrant society where individuals enjoy good health and a high quality of life by providing comprehensive and innovative healthcare throughout the Kingdom.

Go up